avail
effect
vaccin
profound
posit
effect
improv
qualiti
public
health
prevent
infecti
diseas
despit
mani
success
vaccin
still
old
new
emerg
pathogen
vaccin
avail
better
understand
vaccin
work
provid
protect
help
improv
current
vaccin
well
develop
effect
vaccin
pathogen
proper
mean
control
recent
studi
focus
innat
immun
first
line
host
defens
role
induc
adapt
immun
studi
intens
area
research
reveal
immunolog
mechan
vaccin
work
protect
tolllik
receptor
tlr
famili
receptor
pathogenassoci
molecular
pattern
cell
innat
immun
system
play
critic
role
detect
respond
microbi
infect
importantli
innat
immun
system
modul
quantiti
qualiti
longterm
b
cell
memori
protect
immun
respons
pathogen
limit
studi
suggest
vaccin
mimic
natur
infect
andor
structur
pathogen
seem
effect
induc
longterm
protect
immun
better
understand
similar
differ
molecular
cellular
event
host
respons
vaccin
pathogen
infect
would
enabl
rational
design
novel
prevent
measur
mani
challeng
pathogen
vertebr
evolv
defens
immun
system
elimin
pathogen
bodi
mammalian
immun
system
two
major
branch
innat
adapt
immun
innat
immun
system
recogn
pathogen
associ
molecular
pattern
limit
number
germlin
encod
pathogen
recognit
receptor
prr
innat
immun
respons
rel
nonspecif
recogn
pathogen
induc
immun
memori
contrast
adapt
immun
system
util
larg
repertoir
rearrang
receptor
innat
immun
system
act
earli
phase
front
line
host
defens
wherea
adapt
immun
play
major
role
elimin
pathogen
late
phase
infect
well
gener
immunolog
memori
hallmark
vertebr
adapt
immun
system
abil
rememb
encount
foreign
antigen
even
whole
lifetim
case
vaccin
pathogen
antigen
kaech
et
al
acquir
immun
develop
clonal
select
vast
repertoir
lymphocyt
bear
antigenspecif
receptor
pregener
via
mechan
gener
known
gene
rearrang
earli
development
stage
burrow
cooper
fundament
characterist
host
immun
system
gener
immunolog
memori
provid
rational
vaccin
effect
measur
prevent
infecti
diseas
induct
longterm
protect
immun
goal
develop
success
safe
vaccin
order
develop
effect
vaccin
specul
intrins
properti
vaccin
antigen
need
design
mimic
pathogen
host
immun
system
like
recogn
vaccin
foreign
antigen
like
pathogen
send
danger
signal
host
innat
immun
system
start
react
vaccin
antigen
activ
adapt
immun
rememb
antigen
howev
success
vaccin
empir
deriv
plotkin
rappuoli
therefor
immunolog
mechan
explain
success
vaccin
induc
longterm
protect
immun
remain
larg
unknown
innat
immun
system
also
recogn
import
control
microbi
infect
major
anim
speci
effect
respons
control
microbi
infect
seem
requir
sever
level
interact
innat
adapt
immun
system
recent
studi
suggest
induct
costimulatori
molecul
secret
cytokin
chemokin
cell
innat
immun
system
significantli
affect
qualiti
quantiti
b
cell
adapt
immun
system
review
describ
current
understand
molecular
cellular
event
innat
adapt
immun
cell
recogn
vaccin
antigen
comparison
live
viral
infect
two
major
type
vaccin
replic
live
attenu
vaccin
nonrepl
vaccin
fig
live
viral
vaccin
effici
trigger
activ
innat
im
mune
system
recogn
vaccin
pathogenassoci
signal
viral
rna
pattern
recognit
receptor
fig
follow
inject
replic
live
viral
particl
microorgan
rapidli
dissemin
host
immun
organ
tissu
throughout
vascular
network
inject
mimick
natur
infect
includ
initi
mucos
replic
vaccin
administ
nasalor
rout
therefor
dendrit
cell
dc
antigen
present
cell
activ
multipl
site
migrat
toward
correspond
lymphoid
organ
lymph
node
spleen
initi
adapt
immun
b
cell
activ
phenomenon
explain
gener
higher
immunogen
live
vaccin
bachmann
et
al
site
rout
inject
live
viral
vaccin
make
signific
differ
dissemin
live
vaccin
nonliv
vaccin
includ
subunit
vaccin
protein
polysaccharid
glycoconjug
kill
microorgan
may
still
contain
prr
capabl
initi
innat
respons
van
duin
et
al
absenc
microbi
replic
nonliv
vaccin
local
activ
innat
respons
site
inject
mark
antigen
dose
spare
effect
observ
intraderm
immun
rabi
mani
countri
probabl
due
high
number
dc
skin
dermi
chen
gluud
de
lalla
et
al
also
intraderm
skin
immun
influenza
vaccin
shown
effect
induc
predict
protect
immun
respons
alarcon
et
al
auewarakul
et
al
khanlou
et
al
van
damm
et
al
therefor
site
rout
administr
may
result
differ
immun
respons
compar
studi
live
influenza
viru
heatinactiv
viru
formalininactiv
deterg
split
influenza
vaccin
three
type
vaccin
induc
prolifer
human
peripher
blood
mononuclear
cell
pbmc
similar
level
blazev
et
al
howev
split
influenza
vaccin
induc
significantli
lower
level
compar
live
heatinactiv
whole
virus
upon
stimul
pbmc
live
viru
stimul
pbmc
cultur
induc
influenzaspecif
cytotox
lymphocyt
activ
upregul
express
level
costimulatori
molecul
human
leukocyt
antigendr
hladr
high
level
therefor
formul
nonliv
vaccin
includ
adjuv
trigger
suffici
activ
innat
system
danger
signal
pashin
et
al
nonetheless
degre
innat
immun
activ
live
vaccin
seem
exceed
nonliv
vaccin
even
use
adjuv
propos
tlr
signal
network
modifi
previou
report
barton
medzhitov
kawai
akira
lee
et
al
myeloid
differenti
factor
tirap
trif
tollinterleukin
receptor
tir
domaincontain
adaptor
protein
tram
trifrel
adaptor
molecul
gtpase
belong
ra
famili
phosphoinositid
akt
kinas
involv
signal
pathway
irak
receptorassoci
kinas
nuclear
factor
kappa
b
activ
irf
interferon
regulatori
factor
rant
regul
upon
activ
normal
cell
express
secret
tak
transform
growth
factor
kinas
ikk
ikappa
b
kinas
complex
mapk
mitogenactiv
protein
kinas
erk
extracellular
signalregul
kinas
jnk
cjun
ntermin
kinas
pathogen
recognit
receptor
prr
common
characterist
pulendran
prr
recogn
microbi
compon
known
pathogen
associ
molecular
pattern
like
essenti
surviv
microorgan
therefor
conserv
microorgan
prr
express
constitut
host
detect
pathogen
intermedi
product
pathogen
lifecycl
prr
germlin
encod
nonclon
independ
immunolog
memori
differ
prr
react
specif
microbi
compon
differ
self
show
distinct
express
pattern
activ
specif
signal
pathway
drive
biolog
respons
pathogen
tolllik
receptor
tlr
import
famili
prr
beutler
et
al
germain
tlr
highli
conserv
worm
mammal
tlr
type
integr
membran
glycoprotein
extracellular
domain
contain
vari
number
leucinerichrepeat
motif
cytoplasm
signal
domain
homolog
interleukin
receptor
term
homolog
domain
bowi
oneil
thu
molecul
involv
tlr
signal
share
signal
howev
signal
pathway
individu
tlr
divid
sever
subfamili
base
primari
sequenc
tlr
subfamili
recogn
relat
pathogen
compon
subfamili
react
bacteri
lipid
zymosan
wherea
highli
relat
recogn
viral
bacteri
nucleic
acid
fig
known
recogn
doubl
strand
rna
viral
rna
compon
togeth
extracellular
compon
surfac
molecul
recogn
structur
differ
ligand
lipopolysaccharid
lp
gramneg
bacteria
caus
septic
shock
glycosylphosphatidlyinositol
gpi
anchor
protein
bind
bacteri
lp
virus
cell
surfac
interact
variou
tlr
induc
cytokin
viru
bacteri
infect
lee
et
al
recogn
bacteri
flagellin
gewirtz
et
al
howev
tlr
recogn
sever
structur
unrel
ligand
exampl
also
known
recogn
fusion
protein
respiratori
syncyti
viru
rsv
fibronectin
heatshock
protein
van
der
sluij
et
al
form
heterodim
discrimin
recogn
peptidoglycan
lipopeptid
lipoprotein
gramposit
bacteria
mycobacterium
tuberculosi
lipoprotein
mycoplasma
lipopeptid
fungal
zymosan
shin
et
al
type
cell
express
tlr
divers
tlr
express
variou
immun
cell
includ
macrophag
dendrit
cell
dc
b
cell
specif
type
cell
cairn
et
al
gururajan
et
al
even
nonimmun
cell
fibroblast
epitheli
cell
express
tlr
express
tlr
static
rather
regul
rapidli
respons
pathogen
varieti
cytokin
environment
stress
furthermor
differ
tlr
express
extraor
intracellularli
tlr
express
cell
surfac
wherea
tlr
found
almost
exclus
intracellular
compart
endosom
thu
ligand
mainli
nucleic
acid
requir
intern
endosom
signal
occur
anoth
import
famili
prr
ctype
lectin
play
key
role
induct
immun
respons
numer
pathogen
repres
ctype
lectin
dendrit
cell
dc
specif
grab
nonintegrin
dcsign
dcassoci
ctype
shape
immun
respons
variou
pathogen
among
pathogen
interact
dcsign
human
immunodefici
viru
type
known
induc
specif
gene
transcript
profil
via
nfkappa
b
subunit
den
dunnen
et
al
recogn
pathogen
tlrligand
interact
result
trigger
downstream
signal
cascad
product
proinflammatori
cytokin
chemokin
akira
takeda
akira
tlr
except
use
downstream
adaptor
molecul
myeloid
differenti
factor
wherea
also
part
signal
via
adaptor
trif
domaincontain
adaptor
induc
shown
fig
tlr
ligat
result
activ
transcript
factor
complex
cascad
signal
molecular
event
inflammatori
cytokin
gene
induc
tlr
interact
includ
ligat
tlr
also
elicit
upregul
costimulatori
molecul
chemokin
tnfalpha
rant
depend
type
ligand
tlr
import
step
induc
pathogen
vaccin
antigen
specif
adapt
immun
respons
furthermor
tlr
tlr
capabl
induc
type
interferon
elicit
antivir
respons
antigenpres
cell
apc
dc
macrophag
promin
express
tlr
apc
ingest
degrad
pathogen
play
critic
role
activ
innat
immun
system
well
initi
activ
adapt
immun
cell
apc
also
activ
adapt
immun
respons
migrat
infect
site
region
lymph
node
induct
b
cell
respons
occur
induct
effect
antigenspecif
b
cell
respons
requir
activ
specif
apc
ingest
antigen
among
apc
dc
known
uniqu
potent
capac
provid
antigenspecif
activ
well
costimulatori
signal
cell
possibl
b
cell
also
pasar
medzhitov
danger
signal
requir
activ
cell
palucka
et
al
therefor
first
requir
vaccin
effect
provid
suffici
danger
signal
dc
vaccin
antigen
andor
adjuv
trigger
inflammatori
reaction
certain
degre
mediat
cell
innat
immun
system
kwissa
et
al
vaccin
compon
shown
abl
activ
innat
prr
exampl
live
attenu
yellow
fever
vaccin
one
effect
vaccin
demonstr
activ
multipl
dc
subset
via
tlr
querec
et
al
intracellular
pathogen
infect
like
recogn
doubl
strand
singl
strand
viral
rna
respect
also
live
attenu
coldadapt
influenza
vaccin
like
activ
tlr
intracellular
replic
lead
upregul
inflammatori
cytokin
diebold
le
goffic
et
al
demonstr
activ
bacteri
viral
dna
contain
unmethyl
cpg
motif
hemmi
et
al
vaccin
adjuv
select
properti
activ
tlr
monophosphoryl
lipid
mpa
deriv
lp
activ
cpg
dna
oligonucleotid
activ
bacteri
flagellin
activ
respect
gewirtz
et
al
martin
et
al
tlr
agonist
deriv
demonstr
effect
enhanc
immunogen
coadminist
vaccin
antigen
clinic
trial
pers
et
al
tiberio
et
al
activ
dc
upregul
costimulatori
molecul
mostli
prrmediat
recognit
pathogen
vaccin
antigen
instruct
differenti
naiv
cell
helper
cell
cell
pasar
medzhitov
also
certain
subset
dc
initi
activ
matur
adapt
immun
cell
includ
cell
b
cell
duboi
et
al
thu
innat
immun
key
element
inflammatori
respons
well
initi
adapt
immun
respons
pathogen
vaccin
activ
multipl
innat
prr
expect
effect
induc
protect
immun
regard
infect
particularli
rna
virus
mammalian
host
innat
immun
respons
two
major
pathway
control
viru
infect
one
involv
tlr
mediat
signal
pathway
recognit
viral
genom
intermedi
mediat
cytoplasm
rna
helicas
retino
acid
induc
gene
rig
melanoma
differenti
associ
gene
recogn
triphosphoryl
doubl
strand
viral
rna
respect
activ
host
antivir
innat
immun
system
loo
et
al
takeshita
et
al
howev
virus
evolv
mean
innat
immun
evas
order
establish
product
infect
produc
protein
inhibit
signal
cascad
prr
innat
immun
system
unterholzn
bowi
vaccinia
viru
suppress
innat
immun
signal
doublestrand
rna
bind
protein
inhibit
mitochondri
antivir
signal
protein
mav
adaptor
cytoplasm
viral
rna
sensor
rigi
deng
et
al
also
influenza
nonstructur
protein
known
inhibit
product
antivir
cytokin
matur
dc
probabl
bind
viral
rna
result
hide
danger
signal
host
fernandezsesma
et
al
li
et
al
influenza
virus
contain
mutant
protein
show
attenu
phenotyp
still
maintain
immunogen
mutat
influenza
protein
suggest
use
approach
develop
effect
live
influenza
vaccin
hai
et
al
pales
et
al
talon
et
al
therefor
inform
virushost
interact
provid
import
insight
develop
viral
vaccin
vector
attenu
live
viru
vaccin
innat
tlr
signal
adapt
b
cell
immun
respons
b
cell
express
membran
bound
antibodi
molecul
call
b
cell
receptor
specif
antigen
select
clone
b
cell
develop
bone
marrow
b
cell
one
import
adapt
immun
compon
furthermor
recent
studi
suggest
b
cell
also
express
tlr
involv
host
innat
immun
system
gururajan
et
al
mansson
et
al
follicular
b
cell
mice
express
tlr
gururajan
et
al
b
cell
also
show
prolif
respons
upon
stimul
poli
c
lipopolysaccharid
agonist
isotyp
switch
antibodi
found
secret
cultur
supernat
upon
tlr
agonist
stimul
b
cell
gururajan
et
al
controversi
regard
whether
tlr
signal
essenti
b
cell
respons
gener
vaccin
nemaze
et
al
pasar
medzhitov
compar
antibodi
respons
induc
wild
type
tlr
signalingdefici
mice
trif
knockout
immun
hapten
conjug
highli
immunogen
protein
antigen
hemocyanin
keyhol
limpet
hemocyanin
chemic
coupl
hapten
trinitrophenol
presenc
differ
type
adjuv
aluminium
hydroxid
completeincomplet
freund
adjuv
monophosphoryllipid
studi
gavin
et
al
conclud
tlr
signal
essenti
induc
antibodi
respons
highli
immunogen
protein
antigen
presenc
strong
adjuv
also
demonstr
b
cellintrins
tlr
signal
requir
humor
immun
hapten
np
conjug
chicken
gamma
globulin
coadminist
aluminium
hydroxid
adjuv
meyerbahlburg
et
al
contrast
studi
demonstr
tlr
signal
b
cell
play
critic
role
induc
antibodi
product
isotyp
switch
infect
virus
parasit
induc
class
switch
markinegoriaynoff
et
al
indic
possibl
role
tlr
signal
b
cell
class
switch
addit
ligand
cpg
b
cell
cultur
induc
product
antibodi
lin
et
al
liu
et
al
isotyp
switch
correl
increas
express
transcript
factor
tbet
mice
shown
profound
defect
activ
antigen
specif
immun
respons
includ
isotyp
switch
immun
ovalbumin
plu
complet
freund
adjuv
schnare
et
al
defici
mice
signal
defici
b
cell
sever
impair
induc
igg
antibodi
product
human
serum
albumin
ovalbumin
administ
lipopolysaccharid
pasar
medzhitov
inform
obtain
use
model
antigen
care
evalu
translat
vaccin
valid
clinic
relev
vaccin
like
weakli
immunogen
antigen
eg
solubl
protein
fail
effect
induc
igg
antibodi
respons
absenc
tlr
ligand
contrast
immunogen
antigen
adjuv
might
abl
induc
antibodi
respons
without
tlr
signal
host
respons
upon
immun
live
versu
inactiv
vaccin
would
quit
differ
infect
mice
defici
either
promot
stimul
signal
could
induc
antivir
respons
although
significantli
lower
titer
total
antiinfluenza
hemagglutinin
igg
antibodi
wt
mice
koyama
et
al
contrast
vaccin
either
defici
mice
inactiv
viru
show
significantli
lower
virusspecif
antibodi
level
surviv
rate
role
tlr
innat
signal
regul
function
b
cell
vaccin
remain
determin
clinic
relev
vaccin
goal
vaccin
induc
longterm
protect
immun
hallmark
adapt
immun
contrast
innat
immun
immunolog
memori
longterm
protect
immun
provid
vaccin
antigen
pathogen
specif
immun
effector
induct
immun
memori
cell
effici
rapidli
reactiv
upon
pathogen
exposur
kalia
et
al
quan
et
al
vaccin
licens
far
induc
antibodi
produc
b
cell
like
respons
longterm
protect
vaccin
crotti
et
al
rappuoli
anoth
adapt
immun
compon
contribut
protect
cytotox
lymphocyt
ctl
limit
spread
infecti
agent
recogn
kill
infect
cell
secret
antivir
cytokin
kaech
et
al
helper
cell
support
gener
mainten
b
cell
respons
antibodi
prevent
reduc
infect
extraand
intracellular
agent
wherea
cell
prevent
infect
reduc
control
intracellular
pathogen
howev
longev
cell
immun
vaccin
remain
unknown
addit
vaccin
pure
base
cell
immun
demonstr
yet
rappuoli
vaccin
antigen
pathogen
bind
b
cell
receptor
antibodi
membranebound
form
trigger
express
earli
activ
marker
sancho
et
al
well
chemokin
receptor
drive
antigenspecif
b
cell
toward
cell
zone
secondari
lymphoid
tissu
mcheyzerwilliam
mcheyzerwilliam
reif
et
al
locat
vaccin
antigenspecif
b
cell
like
interact
recent
activ
cell
dc
follicular
dc
specif
surfac
molecul
cell
help
rapidli
drive
b
cell
differenti
antibodi
secret
shortliv
plasma
cell
produc
lowaffin
germlin
encod
antibodi
kelso
b
cell
process
vaccin
antigen
small
peptid
display
peptid
antigen
surfac
mhc
major
histocompat
complex
class
ii
molecul
mhc
iipeptid
complex
b
cell
dc
becom
avail
bind
specif
subset
cell
follicular
helper
cell
vinuesa
et
al
helper
cell
follicl
stimul
b
cell
return
costimulatori
molecul
ico
cytokin
vaccin
antigenspecif
b
cell
receiv
suffici
help
antigenspecif
cell
initi
germin
center
reaction
develop
germin
center
gc
follicular
dc
attract
antigenspecif
activ
b
cell
express
receiv
addit
activ
surviv
signal
follicular
dc
follicular
cell
b
cell
undergo
massiv
clonal
prolifer
result
antibodi
class
switch
igg
isotyp
iga
affin
matur
b
cell
b
cell
gc
bind
affin
peanut
agglutinin
typic
character
increas
express
fa
decreas
express
ridderstad
tarlinton
shinal
et
al
gc
reaction
b
cell
undergo
somat
hypermut
immunoglobulin
ig
variabl
gene
segment
high
affin
igg
antibodi
protein
vaccin
antigen
begin
appear
blood
day
prime
indic
develop
gc
reaction
requir
coupl
week
flehmig
et
al
kelso
gc
respons
control
magnitud
b
cell
differenti
plasma
cell
blink
et
al
mcheyzerwilliam
mcheyzerwilliam
posit
select
highaffin
b
cell
may
migrat
plasma
foci
becom
antibodyproduc
cell
migrat
bone
marrow
becom
longliv
plasma
cell
differenti
longliv
memori
b
cell
crotti
et
al
kalia
et
al
usual
take
week
peak
level
igg
vaccin
antibodi
secret
blood
stream
primari
immun
depend
dosag
natur
vaccin
demonstr
preliminari
studi
influenza
particul
solubl
vaccin
song
et
al
unpublish
data
also
found
lower
dose
particul
vaccin
took
longer
time
level
antibodi
reach
peak
quan
et
al
unpublish
data
natur
vaccin
immunogen
vaccin
antigen
type
adjuv
seem
affect
cellular
interact
among
dc
b
cell
follicular
helper
cell
follicular
dc
determin
qualiti
quantiti
antibodi
respons
inform
molecular
cellular
event
lead
product
highaffin
antibodi
obtain
use
haptenconjug
model
antigen
similar
studi
use
clinic
meaning
vaccin
perform
provid
inform
insight
design
effect
vaccin
fraction
plasma
cell
gener
gc
reaction
acquir
capac
migrat
toward
longterm
surviv
nich
mostli
locat
within
bone
marrow
bm
produc
vaccineinduc
antibodi
extend
period
ming
wol
et
al
shapiroshelef
calam
plasma
cell
character
express
marker
plasma
cell
differenti
chilosi
et
al
mechan
vaccineinduc
antibodi
level
maintain
mani
year
remain
yet
undefin
may
depend
natur
vaccin
antigen
manz
et
al
presenc
polyclon
stimul
differenti
memori
b
cell
plasma
cell
continu
antigenindepend
manner
bernasconi
et
al
regardless
exact
mechan
support
bm
plasma
cell
surviv
durat
magnitud
antibodi
respons
like
determin
number
longliv
plasma
cell
gener
vaccin
antibodi
persist
may
reliabl
predict
antibodi
titer
reach
time
month
immun
level
antibodi
presum
maintain
longliv
plasma
cell
predict
mathemat
model
hepat
vaccin
honorati
et
al
van
herck
et
al
complementconsist
group
serum
protein
work
part
innat
immun
system
play
import
role
maintain
longterm
antibodi
respons
possibl
mechan
complement
regul
b
cell
respons
lower
signal
threshold
b
cell
receptor
engag
complement
receptor
complex
b
cell
gustavsson
et
al
hebel
et
al
colig
complement
receptor
b
cell
receptor
shown
lower
threshold
b
cell
activ
carter
fearon
carter
et
al
importantli
absenc
costimul
receptor
complex
postgc
b
cell
unabl
upregul
plasma
cell
transcript
factor
result
failur
gc
b
cell
differenti
longliv
plasma
cell
gatto
et
al
therefor
complement
import
immun
compon
enhanc
b
cell
respons
establish
longterm
memori
igg
antibodi
respons
vaccin
howev
antigen
induc
immun
respons
absenc
complement
live
vesicular
stomat
influenza
virus
abl
induc
normal
immun
respons
complementdefici
mice
kopf
et
al
ochsenbein
et
al
virus
possess
highli
organ
repetit
structur
capac
crosslink
b
cell
receptor
may
account
decreas
depend
complement
signal
memori
b
cell
gener
parallel
plasma
cell
gc
reaction
tdepend
vaccin
mcheyzerwilliam
mcheyzerwilliam
unless
reexposur
antigen
drive
differenti
antibodi
produc
plasma
cell
memori
b
cell
produc
antibodi
reactiv
rapid
process
character
immedi
increas
higher
titer
antibodi
higher
affin
antigen
antibodi
gener
primari
respons
memori
b
cell
may
thu
recal
lower
amount
antigen
absenc
cell
help
mcheyzerwilliam
mcheyzerwilliam
reactiv
prolifer
differenti
memori
b
cell
occur
without
requir
gc
reaction
process
thu
much
rapidli
complet
primari
respons
studi
demonstr
window
day
suffici
induc
high
level
antigenspecif
vaccin
antibodi
previous
prime
infant
pichichero
et
al
mice
quan
et
al
viruslik
particl
vlp
promis
vaccin
platform
live
bacteri
viral
vaccin
effici
activ
innat
immun
system
presum
pathogenassoci
signal
allow
recognit
prr
follow
vaccin
live
viral
vaccin
mimick
natur
infect
apc
includ
dc
activ
multipl
site
migrat
toward
drain
lymph
node
initi
adapt
immun
system
b
cell
effect
explain
empir
success
exampl
approv
live
vaccin
includ
smallpox
rabi
tuberculosi
yellow
fever
polio
measl
adenoviru
rotaviru
coldadapt
influenza
viru
plotkin
howev
vaccin
live
vaccin
safeti
concern
restrict
applic
divers
popul
addit
pathogen
difficult
grow
exampl
human
hepat
c
viru
requir
high
biosafeti
facil
highli
train
personnel
handl
live
pathogen
exampl
ebola
avian
influenza
virus
addit
live
vaccin
would
accept
certain
highli
pathogen
virus
aid
hemorrhag
fever
virus
ebola
marburg
dengu
lassa
fever
rift
valley
fever
hantaviru
bacteri
pathogen
yersinia
pesti
francisella
tularensi
tularemia
vaccin
avail
altern
live
viral
vaccin
approach
develop
vaccin
mimick
viral
structur
would
desir
structur
protein
mani
virus
abil
assembl
repeat
organ
structur
viruslik
particl
vlp
shown
fig
vlp
vaccin
produc
cell
express
recombin
structur
protein
interest
use
genet
engin
recombin
technolog
exampl
licens
vaccin
human
hepat
b
viru
papillomaviru
base
concept
vlp
vlp
within
gener
rang
viral
size
nm
exact
size
morpholog
depend
particular
viral
protein
incorpor
vlp
noninfecti
assembl
absenc
viral
genom
particul
natur
repetit
high
densiti
display
epitop
like
optim
activ
innat
immun
system
well
bind
trigger
b
cell
receptor
lead
strong
immun
respons
less
depend
cell
help
live
virus
trigger
tlr
innat
immun
activ
signal
lead
switch
isotyp
antibodi
respons
laboratori
found
immun
mice
influenza
vlp
induc
antibodi
domin
isotyp
indic
possibl
vlp
might
activ
immun
respons
trigger
tlrmediat
innat
immun
signal
bright
et
al
jegerlehn
et
al
quan
et
al
isotyp
known
promot
cascad
complement
activ
thu
effici
clear
viral
bacteri
infect
couteli
et
al
klau
et
al
nimmerjahn
ravetch
therefor
studi
laboratori
suggest
vlp
promis
approach
evidenc
preclin
studi
develop
vaccin
viral
pathogen
includ
influenza
polioviru
rotaviru
ebola
marburg
norwalk
viru
sever
acut
respiratori
syndrom
coronaviru
bertolotticiarlet
et
al
deml
et
al
galarza
et
al
grgacic
anderson
lobu
et
al
mortola
roy
pushko
et
al
quan
et
al
sun
et
al
warfield
et
al
influenza
vlp
produc
insect
cell
use
recombin
baculoviru
express
system
demonstr
induc
protect
immun
lethal
challeng
pathogen
season
pandem
influenza
virus
bright
et
al
quan
et
al
also
found
level
protect
influenza
viru
specif
antibodi
maintain
month
post
immun
mice
influenza
vlp
absenc
adjuv
quan
et
al
vlp
shown
induc
neutral
antibodi
well
cellular
immun
respons
anim
model
buonaguro
et
al
deml
et
al
kang
et
al
quan
et
al
sailaja
et
al
vlp
shown
highli
immunogen
induc
protect
immun
respons
without
adjuv
solubl
subunit
vaccin
poorli
immunogen
usual
requir
nonspecif
inflammatori
stimuli
adjuv
induc
protect
immun
respons
bachmann
et
al
therefor
vlp
promis
format
develop
vaccin
studi
better
understand
underli
mechan
nonrepl
vlp
activ
innat
immun
system
lead
induct
longterm
protect
immun
respons
studi
suggest
hiv
vlp
induc
matur
dc
monocytemacrophag
popul
evidenc
upregul
activ
marker
cytokin
sailaja
et
al
vlp
antigenload
dc
activ
adapt
immun
cell
includ
b
cell
sailaja
et
al
administr
vlp
mice
induc
acut
activ
multipl
type
immun
cell
involv
innat
adapt
immun
system
express
earli
activ
marker
downregul
home
receptor
sailaja
et
al
use
microarray
approach
stimul
monocytederiv
dc
peripher
blood
mononuclear
cell
hiv
vlp
induc
signific
chang
gene
express
profil
demonstr
possibl
molecular
event
involv
dc
activ
matur
might
occur
nonrepl
vlp
vaccin
buonaguro
et
al
vlp
induc
chang
observ
sever
pathway
includ
cytoskelet
gene
may
potenti
mediat
migratori
behavior
activ
dc
increas
express
level
gene
relat
immun
cytokin
chemokin
receptor
contribut
recruit
monocyt
dc
macrophag
infect
site
function
implic
gene
show
increas
transcript
level
evalu
respons
hiv
vlp
stimul
dc
buonaguro
et
al
eselectin
sele
chemokin
cc
motif
receptor
like
express
matur
dc
follow
exposur
vlp
antigen
favor
interact
endotheli
cell
migrat
peripher
tissu
cell
area
secondari
lymphoid
organ
set
cytokin
receptor
share
common
gamma
chain
also
upregul
promot
dc
respond
lymphocyt
deriv
interleukin
within
lymph
node
addit
increas
level
express
secret
cytokin
may
contribut
prime
cell
trigger
effector
tcell
respons
inform
level
gene
express
support
evid
vlp
develop
effect
vaccin
capabl
induc
cellular
immunog
differenti
dc
potent
immun
compon
link
innat
adapt
immun
system
support
influenza
vlp
demonstr
induc
potent
protect
immun
without
use
adjuv
bright
et
al
quan
et
al
recent
studi
understand
host
respons
upon
pathogen
exposur
provid
evid
molecular
recognit
pathogen
cell
innat
immun
system
play
signific
role
determin
natur
adapt
b
cell
immun
respons
key
area
research
understand
molecular
cellular
innat
immun
mechan
success
vaccin
induc
longlast
protect
immun
respons
specif
role
differ
tlr
prr
innat
immun
receptor
play
induc
differenti
longliv
memori
b
cell
plasma
cell
role
b
cell
intrins
tlr
play
gener
longliv
memori
b
cell
plasma
cell
addit
role
play
nontlr
viral
sensor
rigi
mav
protein
kinas
r
mediat
effect
adapt
immun
remain
defin
evid
relat
role
innat
immun
collect
studi
use
infecti
pathogen
live
vaccin
evid
live
vaccin
excel
induc
longlast
protect
immun
still
risk
actual
caus
diseas
vaccin
design
protect
although
inactiv
kill
vaccin
rel
good
induc
protect
antibodi
respons
problem
associ
vaccin
manufactur
safeti
thu
futur
goal
dissect
differ
characterist
virus
instruct
design
recombin
vaccin
integr
immunogen
featur
respons
effect
induc
neutral
antibodi
protect
immun
use
recombin
dna
technolog
nonrepl
vlp
good
exampl
recapit
featur
viru
viral
structur
except
replic
properti
develop
vaccin
howev
molecular
cellular
compon
innat
adapt
immun
respons
induc
protect
immun
nonrepl
vaccin
mostli
remain
undefin
exist
vaccin
licens
far
develop
pathogen
show
limit
antigen
variat
suppos
control
induct
neutral
antibodi
vaccin
case
vaccin
protect
seem
go
beyond
serum
antibodi
level
alon
especi
live
vaccin
mucos
tcellmedi
immun
contribut
protect
difficult
prove
vaccin
individu
pathogen
extrem
variabl
antigen
difficult
make
effect
vaccin
convent
approach
extrem
exampl
rna
viru
gener
antigen
differ
form
daili
absenc
proofedit
properti
presenc
host
immun
pressur
develop
effect
measur
highli
variabl
pathogen
need
better
understand
molecular
cellular
interact
host
pathogen
determin
mucos
tcellmedi
immun
contribut
protect
work
support
nihniaid
grant
rwc
korea
ginseng
societi
sk
thank
laboratori
member
dr
fushi
quan
jaemin
song
contribut
discuss
regret
relat
import
refer
cite
due
space
limit
